UCLA Center for IBD,
Beware of the Swinging Pendulum: Anti-TNF combination therapy Increases the risk of malignancy. #IBD #Crohns #Colitis #Adalimum…
Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
Overview of attention for article published in Gastroenterology, December 2013
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (83rd percentile)
Mentioned by
- blogs
- 1 blog
- policy
- 1 policy source
- 12 X users
- 1 Facebook page
- 2 Redditors
- guideline
- 5 clinical guideline sources
Readers on
- mendeley
- 152 Mendeley